The industry’s final months of 2025 could be action-packed as the FDA renders approval decisions on drugs that would be ...

Wegovy maker Novo Nordisk has cut a U.S. sales team focused on obesity and diabetes education for healthcare providers, ...

"That's an easy move to make out of the gate, but it's also unusual at Novo, and it's piqued investor interest," said ...

Roche Holding AG's acquisition of 89bio, Inc. to expand cardiometabolic offerings and drive growth beyond GLP-1. Click for ...

Now, it’s worth noting Stock Advisor’s total average return is 1,058% — a market-crushing outperformance compared to 189 % ...

With a market cap of $708 billion, Eli Lilly isn't far from becoming the first trillion-dollar healthcare company.

Eli Lilly and Co. (NYSE: LLY) is one of the best beginner stocks to buy, according to analysts. On September 17, the company ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company recently completed a ...

Eli Lilly and Company (NYSE:LLY) is among the high growth mega cap stocks you can buy and hold for the next 3 years. During the first quarter, eCIO Inc.

It is expected to create 650 jobs and is one of four U.S. manufacturing facilities the pharmaceutical giant plans to unveil ...

Eli Lilly's bid for approval for an experimental weight-loss pill got a boost on Wednesday with new clinical trial data, and ...

The Silvant Large Cap Growth SMA returned +18.62% (gross)/+17.74% (net) for the quarter, outperforming the Russell 1000 ...